FAKHRAVAC

Vaccine candidate against COVID-19

Texto en inglés

Último precio

—

Precio mínimo

—

Mediana 7 d

—

Ventas 30 d

Rango 30 d

—

En circulación

Cotización

Ver tabla

Fecha	mediana	Mín	Máx	ventas

Historial de ventas

Última venta: —
Media 30 d: —
Mínimo 30 d: —
Máximo 30 d: —
Ventas 7 d: 0
Ventas 30 d: 0

Aún no hay ventas.

Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.

En Wikipedia

Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.

FAKHRAVAC (Persian: واکسن فخرا) is a COVID-19 vaccine developed in Iran by the Organization of Defensive Innovation and Research, a subsidiary of Iran's Ministry of Defense. It is the third Iranian COVID-19 vaccine reaching clinical trials. It is currently in phase III. It received emergency use authorization in Iran on 9 September 2021. The vaccine is named after the Iranian nuclear scientist Mohsen Fakhrizadeh. According to the Iranian authorities, he was working on a vaccine in response to the COVID-19 pandemic in Iran. Fakhrizadeh was assassinated in November 2020 in an attack Iran and US intelligence attributed to Israel.

Texto: Wikipedia en inglés, CC BY-SA 4.0. · Imagen: Shared by Fars News Agency (CC BY 4.0) ·